Barclays Upgrades Momenta Pharmaceuticals (MNTA) to Overweight

October 11, 2016 6:50 AM EDT
Get Alerts MNTA Hot Sheet
Price: $14.35 -2.71%

Rating Summary:
    10 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade MNTA Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Barclays upgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Equalweight to Overweight with a price target of $19.00 (from $13.00).

For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.

Shares of Momenta Pharmaceuticals closed at $11.77 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot Upgrades, Upgrades

Related Entities

Barclays

Add Your Comment